Report

  • Home |
  • Reports |
  • Global Liquid Biopsy Market by Product Type (Assay kits, Instruments & Services)....
src

Global Liquid Biopsy Market by Product Type (Assay kits, Instruments & Services) and by End-Users/Application (Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centers & Other) Global Market Share, Forecast Data, In-Depth Analysis, and Detailed Overview, and Forecast, 2015 - 2027

The report on the global liquid biopsy market analyzes complete scenario i.e., existing as well as future visions market. It includes detailed overview of liquid biopsy market along with market pictures. Additionally, report has included complete data of the various segments in the global liquid biopsy market followed by its applications, end users and region wide segmentation. Moreover, report has highlights of global key players present in this market. Top global players are analyzed completely along with their financials, technological innovations, key developments, apart from future strategies, SWOT analysis, acquisitions & mergers, and market footprint.

Global liquid biopsy market report offers in-depth insights, revenue details, and other vital information regarding the global liquid biopsy market, and the various trends, drivers, restraints, opportunities, and threats in the target market till year 2027. Hence, it covers the impact of these drivers and restraints on demand for this market during the forecast period. The report also includes PEST analysis, Porter’s Five Forces analysis, and opportunity map analysis for in-depth understanding of the market.

It provides historical data along with future forecast as well as detailed analysis of market on a global, regional and country level. Important market data of this market is projected in the form of form of tables, graphics, and pictures. On a regional basis, the market is categorized into five regions that include North America, Europe, Asia Pacific, Latin America, and Middle & East Africa. It analyzes complete scenario of each and every region along with highest share holder of liquid biopsy market.

Market Segmentation:
Segmentation by Type Assay kits
Instruments
Services
Segmentation by Application Reference Laboratories 
Hospitals and Physician Laboratories
Academic and Research Centers
Other
Market, By Regions North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, and Russia, etc.)
Asia-Pacific (China, Japan, ASEAN, India, and Korea)
The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)
South America (Brazil, Chile, Peru, and Argentina)

In addition, liquid biopsy market report sorted and categorized the information and data according to the major geographical regions which are expected to impact on the industry in forecast period.

Report also provides factors that are contributing to and influencing the expansion of the global liquid biopsy market. It projects the market assessment for the predicted time. Along with all these report includes the manufacturing process along with shipment, price, revenue, gross profit, potential, interview records, business distribution, etc. This enables users to get complete scenario of competitive analysis of the market.

Pivotal Fundamentals of the Global Liquid Biopsy Market Report:
  • Holistic in-depth detailed analysis, regarding the parent market.
  • Detailed information about the current R&D activities performed by each liquid biopsy market player.
  • Region-wise and country-wise breakdown of the liquid biopsy market to get the revenue, and growth lookout in these areas.
  • Key factors which are influencing the consumption pattern of consumers across various regions and countries.
  • Historical and future progress of the global liquid biopsy market.
  • Year-on-year growth of the global liquid biopsy market in terms of value and volume.
Conclusion:
At last report covers a short outline of the dealers, distributors, and suppliers. Additionally, it provides sales channel, analysis findings and results. It spots some new entrants within the market. The study thus, suggests a brand new proposition to embellish liquid biopsy market and nurture business as it explains current global market as well as future market.
Chapter 1 Liquid Biopsy Market Overview
1.1 Product Overview and Scope of Liquid Biopsy

Chapter 2 Executive Summary 
2.1 Drivers for Liquid Biopsy Market: 
2.2 Restrain for Liquid Biopsy Market:
2.3 Opportunity for Liquid Biopsy Market: 
2.4 Global Liquid Biopsy market, 2015 - 2027
2.5 Global Liquid Biopsy market, by Region, 2015 - 2027
2.6 Global Liquid Biopsy market, by Type, 2015 - 2027
2.7 Global Liquid Biopsy market, by Application, 2015 - 2027

Chapter 3 Liquid Biopsy Segment by Types (Product Category) 
3.1 Global Liquid Biopsy Revenue (USD Million) and Growth Rate (%) Comparison by Types (2015-2027) 
3.2 Global Liquid Biopsy Revenue Market Share (%) by Types in 2019
3.3 Assay kits
3.4 Instruments
3.5 Services

Chapter 4 Global Liquid Biopsy Segment by Application 
4.1 Global Liquid Biopsy Revenue (USD Million) Comparison by Application (2015-2027) 
4.2 Reference Laboratories 
4.3 Hospitals and Physician Laboratories
4.4 Academic and Research Centers
4.5 Other

Chapter 5 Global Liquid Biopsy Market by Regions (2015-2027) 
5.1 Global Liquid Biopsy Market Size and Growth Rate (%) Comparison by Regions (2015-2027) 
5.2 North America Liquid Biopsy Status and Prospect (2015-2027) 
5.3 Europe Liquid Biopsy Status and Prospect (2015-2027)
5.4 Asia Pacific Liquid Biopsy Status and Prospect (2015-2027) 
5.5 South America Liquid Biopsy Status and Prospect (2015-2027) 
5.6 Middle East & Africa Liquid Biopsy Status and Prospect (2015-2027) 
5.7 Global Liquid Biopsy Market Size (2015-2027) 
            5.7.1 Global Liquid Biopsy Revenue Status and Outlook (2015-2027) 
            
Chapter 6 Global Liquid Biopsy Market Competition by Manufacturers
6.1 Global Liquid Biopsy Revenue and Share by Manufacturers (2015-2019) 

Chapter 7 Company (Top Players) Profiles and Key Data
7.1 Company 1. QIAGEN N.V. 
            7.1.1 Company 1 Basic Information and Sales Area
            7.1.2 Business Segment/ Overview
            7.1.3 Investment in Research and Development
            7.1.4 Liquid Biopsy Product Types Specification
            7.1.5 Key Developments
            7.1.6 Business Strategy
            7.1.7 Key Financial Data (2015-2019)
7.2 Company 2. Roche Diagnostics
            7.2.1 Company 2 Basic Information and Sales Area
            7.2.2 Business Segment/ Overview
            7.2.3 Investment in Research and Development
            7.2.4 Liquid Biopsy Product Types Specification
            7.2.5 Business Strategy
            7.2.6 Key Financial Data (2015-2019)
7.3 Company 3. Bio-Rad Laboratories Inc.
            7.3.1 Company 3 Basic Information, and Sales Area
            7.3.2 Business Segment/ Overview
            7.3.3 Liquid Biopsy Product Types Specification
            7.3.4 Key Developments
            7.3.5 Business Strategy
            7.3.6 Key Financial Data (2015-2019)
7.4 Company 4. Myriad Genetics
            7.4.1 Company 4 Basic Information and Sales Area. 
            7.4.2 Business Segment/ Overview
            7.4.3 Liquid Biopsy Product Types Specification
            7.4.4 Business Strategy
            7.4.5 Key Financial Data (2015-2019)
7.5 Company 5. Menarini Silicon Biosystems
            7.5.1 Company 5 Basic Information and Sales Area. 
            7.5.2 Business Segment/ Overview
            7.5.3 Liquid Biopsy Product Types Specification
            7.5.4 Business Strategy
            7.6.5 Key Financial Data (2015-2019)
7.6 Company 6. Genomic Health
            7.6.1 Company 6 Basic Information, and Sales Area
            7.6.2 Business Segment/ Overview
            7.6.3 Liquid Biopsy Product Types Specification
            7.6.4 Business Strategy
            7.6.5 Key Financial Data (2015-2019)
7.7 Company 7. Thermo Fisher Scientific Inc.
            7.7.1 Company 7 Basic Information, and Sales Area
            7.7.2 Business Segment/ Overview
            7.7.3 Investment in Research and Development
            7.7.4 Liquid Biopsy Product Types Specification
            7.7.5 Key Developments
            7.7.6 Business Strategy
            7.7.7 Key Financial Data (2015-2019)
7.8 Company 8. Illumina
            7.8.1 Company 8 Basic Information and Sales Area. 
            7.8.2 Business Segment/ Overview
            7.8.3 Liquid Biopsy Product Types Specification
            7.8.4 Business Strategy
            7.8.5 Key Financial Data (2015-2019)
7.9 Company 9. Biocept
            7.9.1 Company 9 Basic Information, and Sales Area
            7.9.2 Business Segment/ Overview
            7.9.3 Liquid Biopsy Product Types Specification
            7.9.4 Business Strategy
            7.9.5 Key Financial Data (2015-2019)
7.10 Company 10. Trovagene
            7.10.1 Company 10 Basic Information, and Sales Area
            7.10.2 Business Segment/ Overview
            7.10.3 Liquid Biopsy Product Types Specification
            7.10.4 Business Strategy
            7.10.5 Key Financial Data (2015-2019)
            
Chapter 8 Global Liquid Biopsy Revenue by Regions (2015-2027) 
8.1 Global Liquid Biopsy Revenue and Market Share (%) by Regions (2015-2027) 

Chapter 9 Global Liquid Biopsy Revenue by Types
9.1 Global Liquid Biopsy Revenue and Market Share (%) by Types (2015-2027) 

Chapter 10 Global Liquid Biopsy Market Analysis by Application
10.1 Global Liquid Biopsy Revenue (USD Million) and Market Share (%) by Application (2015-2027) 
10.2 Global Liquid Biopsy Revenue Growth Rate by Application (2015-2027) 

Chapter 11 North America Liquid Biopsy Market Development Status and Outlook
11.1 North America Liquid Biopsy Market Size (2015-2027) 
            11.1.1 North America Liquid Biopsy Market Size by Type (USD Million) (2015-2027) 
11.2 North America Liquid Biopsy Market Size (2015-2027) 
            11.2.1 North America Liquid Biopsy Market Size by Application (USD Million) (2015-2027) 
11.3 U.S
            11.3.1 U.S. Liquid Biopsy market, by Type, 2015 - 2027
            11.3.2 U.S. Liquid Biopsy market, by Application, 2015 – 2027
11.4 Canada
            11.4.1 Canada Liquid Biopsy market, by Type, 2015 - 2027
            11.4.2 Canada Liquid Biopsy market, by Application, 2015 – 2027
11.5 Mexico
            11.5.1 Mexico Liquid Biopsy market, by Type, 2015 - 2027
            11.5.2 Mexico Liquid Biopsy market, by Application, 2015 – 2027
            
Chapter 12 Europe Liquid Biopsy Market Development Status and Outlook
12.1 Europe Liquid Biopsy Market Size (2015-2027) 
            12.1.1 Europe Liquid Biopsy Market Size by Type (USD Million) (2015-2027) 
12.2 Europe Liquid Biopsy Market Size (2015-2027) 
            12.2.1 Europe Liquid Biopsy Market Size by Application (USD Million) (2015-2027) 
12.3 U.K.
            12.3.1 U.K. Liquid Biopsy market, by Type, 2015 - 2027
            12.3.2 U.K. Liquid Biopsy market, by Application, 2015 – 2027
12.4 Germany
            12.4.1 Germany Liquid Biopsy market, by Type, 2015 - 2027
            12.4.2 Germany Liquid Biopsy market, by Application, 2015 – 2027
12.5 France
            12.5.1 France Liquid Biopsy market, by Type, 2015 – 2027
            12.5.2 France Liquid Biopsy market, by Application, 2015 – 2027
12.6 Italy
            12.6.1 Italy Liquid Biopsy market, by Type, 2015 – 2027
            12.6.2 Italy Liquid Biopsy market, by Application, 2015 – 2027
12.7 Spain
            12.7.1 Spain Liquid Biopsy market, by Type, 2015 – 2027
            12.7.2 Spain Liquid Biopsy market, by Application, 2015 – 2027
12.8 Rest of Europe
            12.8.1 Rest of Europe Liquid Biopsy market, by Type, 2015 – 2027
            12.8.2 Rest of Europe Liquid Biopsy market, by Application, 2015 – 2027
            
Chapter 13 Asia Pacific Liquid Biopsy Market Development Status and Outlook
13.1 Asia Pacific Liquid Biopsy Market Size (2015-2027) 
            13.1.1 Asia Pacific Liquid Biopsy Market Size by Type (USD Million) (2015-2027) 
13.2 Asia Pacific Liquid Biopsy Market Size (2015-2027) 
            13.2.1 Asia Pacific Liquid Biopsy Market Size by Application (USD Million) (2015-2027) 
13.3 China
            13.3.1 China Liquid Biopsy market, by Type, 2015 – 2027
            13.3.2 China Liquid Biopsy market, by Application, 2015 – 2027
13.4 Japan
            13.4.1 Japan Liquid Biopsy market, by Type, 2015 – 2027
            13.4.2 Japan Liquid Biopsy market, by Application, 2015 – 2027
13.5 India
            13.5.1 India Liquid Biopsy market, by Type, 2015 – 2027
            13.5.2 India Liquid Biopsy market, by Application, 2015 – 2027
13.6 Southeast Asia
            13.6.1 Southeast Asia Liquid Biopsy market, by Type, 2015 – 2027
            13.6.2 Southeast Asia Liquid Biopsy market, by Application, 2015 – 2027
            
Chapter 14 South America Liquid Biopsy Market Development Status and Outlook
14.1 South America Liquid Biopsy Market Size (2015-2027) 
            14.1.1 South America Liquid Biopsy Market Size by Type (USD Million) (2015-2027) 
14.2 South America Liquid Biopsy Market Size (2015-2027) 
            14.2.1 South America Liquid Biopsy Market Size by Application (USD Million) (2015-2027) 
14.3 Brazil
            14.3.1 Brazil Liquid Biopsy market, by Type, 2015 – 2027
            14.3.2 Brazil Liquid Biopsy market, by Application, 2015 – 2027 
14.4 Argentina
            14.4.1 Argentina Liquid Biopsy market, by Type, 2015 – 2027
            14.4.2 Argentina Liquid Biopsy market, by Application, 2015 – 2027 
14.5 Colombia
            14.5.1 Colombia Liquid Biopsy market, by Type, 2015 – 2027
            14.5.2 Colombia Liquid Biopsy market, by Application, 2015 – 2027
14.6 Rest of South America
            14.6.1 Colombia Liquid Biopsy market, by Type, 2015 – 2027
            14.6.2 Colombia Liquid Biopsy market, by Application, 2015 – 2027
            
Chapter 15 Middle East & Africa Liquid Biopsy Market Development Status and Outlook
15.1 Middle East & Africa Liquid Biopsy Market Size (2015-2027) 
            15.1.1 Middle East & Africa Liquid Biopsy Market Size by Type (USD Million) (2015-2027) 
15.2 Middle East & Africa Liquid Biopsy Market Size (2015-2027) 
            15.2.1 Middle East & Africa Liquid Biopsy Market Size by Application (2015-2027) 
15.3 UAE
            15.3.1 UAE Liquid Biopsy market, by Type, 2015 – 2027
            15.3.2 UAE Liquid Biopsy market, by Application, 2015 – 2027
15.4 South Africa
            15.4.1 South Africa Liquid Biopsy market, by Type, 2015 – 2027
            15.4.2 South Africa Liquid Biopsy market, by Application, 2015 – 2027
15.5 Egypt
            15.5.1 Egypt Liquid Biopsy market, by Type, 2015 – 2027
            15.5.2 Egypt Liquid Biopsy market, by Application, 2015 – 2027
15.6 Rest of MEA
            15.6.1 Rest of MEA Liquid Biopsy market, by Type, 2015 – 2027
            15.6.2 Rest of MEA Liquid Biopsy market, by Application, 2015 – 2027
            
Chapter 16 Liquid Biopsy Manufacturing Cost Analysis
16.1 Proportion of Manufacturing Cost Structure
            16.1.1 Raw Materials
            16.1.2 Labor Cost
            16.1.3 USA Labor Cost Analysis
            16.1.4 EU Labor Costs Analysis
            16.1.5 China Labor Costs Analysis
            16.1.6 Manufacturing Expenses
            
Chapter 17 Marketing Strategy Analysis, Distributors/ Traders
17.1 Marketing Channel
            17.1.1 Direct Marketing
            17.1.2 Indirect Marketing
            17.1.3 Marketing Channel Development Trend
17.2 Market Positioning
            17.2.1 Pricing Strategy
            
Chapter 18 Research Findings and Conclusion
 
No Methodology
Global Liquid Biopsy Market Trends:
The global Liquid Biopsy is estimated to be worth USD 791.6 million in 2019 and is projected to reach USD 2890.6 million by 2027, at a CAGR of 20.2% from 2020 to 2027.

Liquid biopsy is a minimal invasive medical procedure with the ability to detect the presence of molecular cancer biomarkers in the biological fluids. The derived test results help the doctors in deciding the further steps in the treatment of the patient suffering from cancer. The test principally involves the usage of samples of biological fluids, such as blood, urine, serum, and saliva, among others, and then the enrichment of the samples using different techniques, such as Next Generation Sequencing (NGS), and Polymerase Chain Reaction (PCR), to detect the mutations known to cause cancer.

The key factors driving the growth of this market include increasing prevalence of cancer, increasing preference for noninvasive procedures, and availability of funding for liquid biopsy R&D. Moreover, The growing demand for noninvasive and easy sample collection and the faster diagnosis of cancer is witnessed to augment the growth of the liquid biopsy market during forecasted period. However, Owing to the lack of desired sensitivity and specificity, physicians and laboratories cannot fully rely on liquid biopsies and have to use tissue biopsies in conjugation with liquid biopsies for diagnosing cancer. This factor is likely to restrain the growth of the market.

Global Liquid Biopsy Market, By Type:
Based on product, the liquid biopsy market is segmented into assay kits, instruments, and services. On the basis of type, the assay kit accounted for largest share of total revenue generated. Because of the factors such as the increasing demand for liquid biopsy tests, increasing applications of liquid biopsies, and the need for reliable and specific assays are driving the liquid biopsy market. Thus all these factors are boosting this segment which led to the growth of the liquid biopsy market.

Global Liquid Biopsy, By Application:
Based on end user, the liquid biopsy market is segmented into reference laboratories, hospitals and physician laboratories, academic and research centers, and other. The demand of Global Liquid Biopsy Market is highest from Reference laboratories as they form the largest and fastest-growing end-user segment of the liquid biopsy market. The can be attributed to the large volume of tests being outsourced to reference laboratories from oncologists and hospitals. Thus all these factors are boosting this sector which led to the growth of the liquid biopsy market.

Global Liquid Biopsy market, By Region:
Report covers the region wise analysis, global Liquid biopsy market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Among all, North America leads the global Liquid biopsy market share followed by Asia Pacific & Europe. While the North America leads the global Liquid biopsy market due to the rising older population in the Americas. The rising older population is playing a key role in the increased adoption of liquid biopsy tests. While Growing demand for non-invasive treatment, rising incidence of cancer, and improving healthcare infrastructure are driving the growth of the liquid biopsy market.

Major Market Players:
The research study includes profiles of leading companies operating in the global liquid biopsy market. Key players profiled in the report include: QIAGEN N.V., Roche Diagnostics, Bio-Rad Laboratories Inc., Myriad Genetics, Menarini Silicon Biosystems, Genomic Health, Thermo Fisher Scientific Inc., Illumina, Biocept & Trovagene.
Roche Diagnostics (Switzerland), launched AVENIO circulating tumor DNA (ctDNA) Analysis Kits. The kits include all reagents, bioinformatics and software to make ctDNA testing accessible to all NGS laboratories.

Global Liquid Biopsy Market Report Scope:
Report Parameters Details of Parameter
Market Size 2015-2027
Based Year 2019
Forecast Period Covered 2020-2027
Units for value USD (Million)
Covered Segments Product Type, Applications, Geographic Regions
Product Type Assay kits, Instruments & Services
Applications Reference Laboratories , Hospitals and Physician Laboratories, Academic and Research Centers & Other
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Covered QIAGEN N.V., Roche Diagnostics, Bio-Rad Laboratories Inc., Myriad Genetics, Menarini Silicon Biosystems, Genomic Health, Thermo Fisher Scientific Inc., 
Illumina, Biocept & Trovagene

The report analyzes all the factors which are impacting on the market and on that basis describes the drivers, restraints, and opportunities for the growth of the global liquid biopsy market. Similarly, report provides the all the segmentations along with the qualitative analysis.

Global Liquid Biopsy Market: Product analysis
  • Assay kits
  • Instruments
  • Services
Global Liquid Biopsy Market: Application analysis
  • Reference Laboratories
  • Hospitals and Physician Laboratories
  • Academic and Research Centers
  • Other
Market, By regions:
In addition, liquid biopsy report sorted and categorized the information and data according to the major geographical regions which are expected to impact on the industry in forecast period. Following are the regions we covered in this report:
  • North America (U.S., Canada, Mexico)
  • Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)
  • Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of L.A.)
  • Middle East and Africa (Turkey, GCC, Rest of Middle East)